MEDIPOSTCO.,LTD.

Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.

078160 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
Website:: https://en.medi-post.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDIPOST CO., LTD. is a global biotechnology company specializing in the development and commercialization of umbilical cord blood-derived stem cell therapeutics. The company focuses on regenerative medicine to address unmet medical needs. Its commercialized portfolio includes first-generation products such as CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. Alongside its therapeutic endeavors, MEDIPOST operates a significant private cord blood banking division for the collection and storage of stem cells. The company's research and development pipeline includes next-generation injectable and intravenous treatments for conditions like osteoarthritis (SMUP-IA-01) and diabetic nephropathy (SMUP-IV-01).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for MEDIPOSTCO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-09-03 00:00	Pre-Annual General Meeting Information 주주명부폐쇄기간또는기준일설정	Korean	4.4 KB
2025-09-01 00:00	Report Publication Announcement 기업설명회(IR)개최	Korean	7.4 KB
2025-08-18 00:00	Report Publication Announcement 기업설명회(IR)개최	Korean	7.5 KB

Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Medicon Hellas S.A. Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.	Greece	MEDIC
MEDICOX Co., Ltd. Developing new drugs and building a distribution platform for healthcare solutions.	South Korea	054180
Medigene AG Clinical-stage immuno-oncology firm developing TCR-engineered T cell therapies for solid tumors.	Germany	MDG1
MedinCell S.A. Develops long-acting injectable therapies using proprietary technology to impact global health.	France	MEDCL
MEDINET Co., Ltd. A CDMO for cell therapy and regenerative medicine development & manufacturing.	Japan	2370
Medios AG Compounding patient-specific therapies and supplying specialty pharma for complex conditions.	Germany	ILM1
Medizen Humancare Inc Co., Ltd Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.	South Korea	236340
Medy-Tox Inc. Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.	South Korea	086900
Meito Sangyo Co., Ltd. Produces food products and specialty chemicals for industrial and pharmaceutical applications.	Japan	2207
Merck KGaA A science & tech firm in healthcare, life science, and electronics, advancing human progress.	United States of America	6MK